News
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company ...
Red Velvet's Wendy Signs With New Agency Following Departure From SM + Drops Stunning Profile Photos
Red Velvet's Wendy has found a new agency to call home! On April 25, new entertainment agency ASND, which previously signed ...
We recently published a list of 10 Best Growth Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Ascendis Pharma A/S (NASDAQ:ASND) stands against other ...
Wendy from Red Velvet has signed with a new agency (ASND) after her departure from her previous entertainment company. The ...
ASND thrives amid market volatility, with Yorvipath's strong potential & strategic focus on rare diseases. Click here to find ...
On April 25, ASND revealed that Red Velvet’s Wendy had signed with the label for her individual pursuits, unveiling fresh portrait shots and a teaser clip. The 31-year-old also launched her ...
Buying $1000 In ASND: If an investor had bought $1000 of ASND stock 10 years ago, it would be worth $81,183.25 today based on ...
Shares of Ascendis Pharma (ASND) are down $5.82, or 4%, to $155.33 in morning trading in New York. The move lower began near the open and may ...
Wendy (웬디) has found herself a new home! After departing from SM Entertainment earlier this month, the singer announced she’s ...
RBC Capital analyst Luca Issi initiated coverage with a Buy rating on Ascendis Pharma (ASND – Research Report) yesterday and set a price target ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results